维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="Stenson AL"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Risk factors tor poor virological outcome at 12 months in a workplace-based an- tiretroviral therapy programme in South Africa: a cohort study 显示文摘	Fielding KL Charalambous S Stenson AL	2008	BMC Infect Dis2008，8，：	1
	2	Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa a cohort study 显示文摘	Fielding KL S Charalambous AL Stenson	2008	BMC Infect Dis2008，8，：	1
	3	A phase Ⅰ-Ⅱ study of concomitant chemoradiotherapy with paclitaxel(one-hour infusion),5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer显示文摘	BROCKSTEIN B HARAF D J STENSON K et al	2000	Ann Oncol2000，11，6：	1
	4	Weekly carboplatin and paclitaxel followed by concomitant paclitaxel,fluorouracil,and hydroxyurea chemoradiotherapy:curative and organ-preserving therapy for advanced head and neck cancer显示文摘	VOKES E E STENSON K ROSEN F R et al	2003	J Clin Oncol2003，21，2：	1
	5	Risk factors for poor virological outcome at 12 months in a workplace-based an- tiretroviral therapy programme in South Africa: a cohort study 显示文摘	Fielding KL Charalambous S Stenson AL	2008	BMC Infect Dis2008，73，8：	1
	6	Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in south Africa: a cohort study 显示文摘	Fielding KL Charalambous S Stenson AL	2008	BMC Infect Dis2008，8，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费